AMBER MCELROY: Open Payments
NPI 1184228017 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 34 payments from 9 companies in 2025. Trend: 2023 $221 · 2024 $236 · 2025 $1,143
Food & beverage: $1,027Education: $116
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $454 |
| GENZYME CORPORATION | 6 | $256 |
| Inspire Medical Systems, Inc. | 7 | $221 |
| GlaxoSmithKline, LLC. | 5 | $82 |
| Organogenesis Inc. | 1 | $36 |
| Optinose US, Inc. | 1 | $27 |
| Hikma Pharmaceuticals USA | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: DUPIXENT, INSPIRE, NUCALA, XHANCE, AFFINITY, Ryaltris, XOLAIR.
Industry payments across IN — which companies pay providers there.
